Adam Mostafa Net Worth & Insider Trades

Adam Mostafa - Chief Financial Officer, X4 Pharmaceuticals, Inc

As of July 5, 2023

What is Adam Mostafa's Net Worth?

The current estimated net worth of X4 Pharmaceuticals, Inc's Chief Financial Officer, Adam Mostafa, is estimated to be about $350.17K . Adam Mostafa owns about 80,221 units of X4 Pharmaceuticals, Inc common stock. In the last 3 years at X4 Pharmaceuticals, Inc, Adam Mostafa has sold an estimated value of $325.63K worth.

What is Adam Mostafa's Past Insider Trading?

Adam Mostafa's largest sale order was 10,834 units , worth over $76.7K on September 22, 2020. In total, Adam Mostafa has made about 18 transactions over 3 years of their time at X4 Pharmaceuticals, Inc. Adam Mostafa usually trades in June, with the busiest year in 2022. The most recent transaction was a sale order of 2,641 units , worth over $4.99K on July 5, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adam Mostafa

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Adam Mostafa's' Mailing Address?

  • Mailing address is C/o Abpro Corporation 65 Cummings Park Drive Woburn MA 01801 MA

What are X4 Pharmaceuticals, Inc's Past Insider Trades?

X4 Pharmaceuticals, Inc's most recent insider trade came on September 12, 2023 by Mary Dibiase who sold 2,642 units worth $3.3K . In the last 3 years, insiders at X4 Pharmaceuticals, Inc have sold an estimated value of $1.56M and bought an estimated value of $29.88K worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Paula Ragan, President and CEO,  Adam Mostafa, Chief Financial Officer,  and Mary Dibiase, Chief Operating Officer .

X4 Pharmaceuticals, Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...